5-Amino-1MQ
NOT FDA APPROVEDMetabolic research compound
Also known as: NNMT inhibitor
Not FDA approved. A small-molecule research compound (grouped with peptides in practice), labelled not for human consumption.
Very thin human evidence
- Regulatory standing. Sold as a research chemical, not approved
- Animal / preclinical only. Evidence is largely animal or in-vitro
- No registered human trials. Nothing registered on ClinicalTrials.gov
- 1 cited source. Cited references provided
A read on the weight of evidence and regulatory standing behind this compound. It is not a safety score, not a purity or quality rating, and not medical advice. It is not a claim that this compound treats, cures, or prevents any condition, and not an endorsement or a recommendation to buy or use it. A low score means the evidence is thin — not that a product is unsafe; a high score means the evidence is strong — not that anyone should take it. PLOBT is independent and takes no money from any vendor; no company can pay to change this score.
Speculative for humans. Preclinical (mouse) data on fat loss and metabolism via NNMT inhibition is interesting, but there is no human clinical evidence. Treat all human benefit claims as unproven.
What it is
Inhibits the enzyme NNMT, which in animal studies is linked to fat metabolism and cellular energy handling.
What the research says
Mouse studies only. No human clinical data.
Registered human trials
Live from ClinicalTrials.gov, the US NIH registry of human studies, refreshed daily. Counts studies where 5-Amino-1MQ is the intervention being tested.
No interventional studies for 5-Amino-1MQ are registered on ClinicalTrials.gov. That is not proof it is unsafe or useless, but it means the human evidence here does not come from registered clinical trials, the exact gap the marketing tends to hide.
FDA recalls & enforcement
5-Amino-1MQ has no FDA recall or drug record at all — because it is not an FDA-regulated drug. That absence is not a safety signal. It means this compound is sold outside the system that inspects, tracks and recalls unsafe products in the first place.
Source: openFDA drug enforcement.
What people log it for
Descriptive, based on what users track. Not an endorsement or a suggested use.
Risks & unknowns
- No human safety or efficacy data.
- Gray-market purity varies.
Doses reported in studies & protocols
No established clinical dose. This is not a recommendation.
Purity reality
A COA is the only way to confirm content.
None yet. PLOBT does not publish invented purity numbers. Real third-party COA data, mapped to vendor and batch, is in development — and it is the one thing we refuse to fake.
Sources
We cite peer-reviewed journals, PubMed/PMC, FDA and university sources, not vendor marketing.